Aarhus University Hospital
auh.dkMatched: Aarhus University Hospital Skejby · Aarhus University Hospital
Live pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
352
Active
95
Phase 3
6
Total enrollment
6,036,692
Pipeline matrix
Showing 25 of 25 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| 17-beta estradiol | — | — | — | — | — | 2 | |
| Vaxigrip Tetra Sanofi Pasteur Europe | — | — | — | — | — | 1 | |
| Denosumab | — | — | — | — | — | 1 | |
| Saline | — | — | — | — | — | 1 | |
| Enstilar | — | — | — | — | — | 1 | |
| Nicardipine | — | — | — | — | — | 1 | |
| Glyceryl trinitrate | — | — | — | — | — | 1 | |
| Zoledronate | — | — | — | — | — | 1 | |
| Duloxetine | — | — | — | — | — | 1 | |
| Benztropine Mesylate 0.5 MG and passive placebo RAP | — | — | — | — | — | 1 | |
| acetylsalicyclic acid | — | — | — | — | — | 1 | |
| Clopidogrel | — | — | — | — | — | 1 | |
| Rosuvastatin | — | — | — | — | — | 1 | |
| Atorvastatin | — | — | — | — | — | 1 | |
| Atorvastatin 80 Mg Oral | — | — | — | — | — | 1 | |
| Semaglutide | — | — | — | — | — | 1 | |
| Cabergoline 0.5 MG | — | — | — | — | — | 1 | |
| Cabergoline 1 MG | — | — | — | — | — | 1 | |
| Allogenic adipose derived mesenchymal stem cells | — | — | — | — | — | 1 | |
| HepB mAb19 | — | — | — | — | — | 2 | |
| senicapoc | — | — | — | — | — | 1 | |
| Perampanel | — | — | — | — | — | 1 | |
| Erwinase PK-model for children and young adults with ALL | — | — | — | — | — | 1 | |
| high-dose calcium | — | — | — | — | — | 1 | |
| Molecular analyses | — | — | — | — | — | 1 |
Next readouts
- 2024-01-15
- 2025-01-01
- 2025-08-31
- 2025-09
- 2026-05-01
- 2026-06-30
- 2026-09-30
- 2026-12-31
- 2026-12-31
- 2027-02-01
Top conditions
- Coronary Artery Disease19
- Myocardial Infarction7
- Acute Lymphoblastic Leukemia7
- Quality of Life7
- Metabolic Syndrome6
- Ischemic Heart Disease6
- Inflammation6
- Type 2 Diabetes6
Frequently asked questions about Aarhus University Hospital
- How many clinical trials does Aarhus University Hospital have on ClinicalTrials.gov?
- Aarhus University Hospital is listed as the lead sponsor on 352 clinical trials in ClinicalTrials.gov, 95 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Aarhus University Hospital's trials are in Phase 3?
- 6 of Aarhus University Hospital's trials are in Phase 3, spread across 25 active drug programs.
- What therapeutic areas does Aarhus University Hospital focus on?
- Aarhus University Hospital's most-studied conditions on ClinicalTrials.gov are Coronary Artery Disease, Myocardial Infarction, Acute Lymphoblastic Leukemia, Quality of Life, Metabolic Syndrome.
- When are Aarhus University Hospital's next clinical trial readouts?
- Aarhus University Hospital has 10 upcoming primary-completion readouts tracked here; the soonest is “Residual Disease MEMory in PSOriasis Skin During EnstiLAR® and Narrow-band Ultraviolet B Therapy: The MEMPSOLAR Study”, expected around 2024-01-15.